2m 2m 2m 2m 2m 2m 2m
MONOPAR THERAPE (MNPR)
NASDAQ
$103.39+$0.06 (+0.06%)
Price as of Jul 13, 2026 4:25 PM EDT- $692.2MMarket Cap
- 136.29%1-Year Change
- BiotechnologyIndustry
MONOPAR THERAPE (MNPR)
$103.39+$0.06 (+0.06%)
MNPR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $103.33 | ||
Change | -$3.27 (-3.07%) | ||
Open | $106.15 | ||
High | $106.90 | ||
Low | $100.50 | ||
Previous Close | $106.60 | ||
Volume | 214,650 | ||
30-Day Average Volume | 187,651 | ||
1-Week Change | 6.39% | ||
1-Month Change | 72.88% | ||
1-Year Change | 136.29% | ||
3-Year Change | 2,319.91% | ||
5-Year Change | 268.38% | ||
Fundamentals | |||
Shares Outstanding | 6.7M | ||
Total Assets | $138.0M | ||
Market Cap | $692.2M | ||
Enterprise Value | $639.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$3.9M | ||
Free Cash Flow | -$3.5M | ||
EBIT | -$3.9M | ||
EBITDA | -$3.9M | ||
Net Working Capital | $135.3M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -164 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -225 | ||
PEG | -9 | ||
Price/Free Cash Flow | -199 | ||
Price/Operating Cash Flow | -199 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 08/13/2024 | ||
Earnings & Revenue